Labs a+

What Labs a+ does

Labs a+ is a Rio de Janeiro-based diagnostic medicine brand that operates as a division of Fleury S.A. (CNPJ 60.840.055/0001-31), one of Brazil's largest diagnostic medicine groups. The brand was formed in 2022 through the combination of Labs D'Or and a+ Medicina Diagnóstica, consolidating two Rio-focused diagnostic networks under Fleury S.A.'s umbrella. Labs a+ runs multiple service units across the Rio de Janeiro metropolitan area — including Barra Américas, Ipanema, Bangu, Copacabana, Tijuca, and others — delivering clinical laboratory testing, diagnostic imaging (MRI, CT, ultrasound, X-ray, mammography), and adult, pediatric, and maternal vaccinations.

The company's technology layer is a conventional consumer-facing stack: a web-based digital scheduling platform, a mobile app for booking and result access, and a home collection/home care service for patients who cannot visit a unit. It accepts health-insurance reimbursement (convênios) and supplements out-of-pocket payments with two newer commercial mechanisms: installment plans through a Dr. Cash partnership, and the Pra Você Card for repeat-use credits. The 2026 vaccination portfolio was materially expanded to include Beyfortus (infant RSV), Abrysvo (maternal RSV), Qdenga (dengue), and updated pediatric combination vaccines, broadening per-visit revenue and customer demographics.

Labs a+ generates revenue on a fee-for-service basis: patients pay per lab test, imaging study, or vaccine administered, either out-of-pocket or via health-insurance reimbursement. Go-to-market is omnichannel — physical units, home service, and digital booking — targeted primarily at individual consumers and secondarily at insurance-routed patients in Rio de Janeiro. As a non-publicly-listed brand within a publicly listed parent, Labs a+ does not separately disclose revenue, and growth is signaled through unit expansion, vaccine launches, and new payment partnerships rather than top-line reporting.

Name

Labs a+

Legal name

Labs a+ Medicina Diagnóstica

Website

https://labsamais.com.br

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Labs a+ is a Rio de Janeiro diagnostic medicine brand and operating division of Fleury S.A., running multiple service units across the metro area to deliver clinical laboratory testing, diagnostic imaging, and vaccination services to individual consumers and health-insured patients.

Ownership category

akta.pro rank

Product category

Medical Diagnostic Services

NAICS

Medical Laboratories (621511), Diagnostic Imaging Centers (621512)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

At-Home Lab Testing & Diagnostics-Integrated Virtual Care (HLALAAAE)

akta.pro secondary industry

Central Laboratory Services (Core Lab Operations) (HLAGAEAA)

Keywords

• Diagnostic laboratory services
• Medical imaging services
• Vaccination services
• Clinical diagnostic testing
• Home healthcare services

Headquarters

HQ city

Santo Amaro

HQ country

Brazil

HQ region

Latin America

Offices21 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Clinical Laboratory Tests: Laboratory diagnostic services including blood tests, urine tests, and other clinical analyses performed at physical units or via home collection.
2. Diagnostic Imaging Services: Imaging services including MRI, tomography, ultrasound, mammography, densitometry, and other diagnostic imaging procedures.
3. Vaccination Services: Vaccination services for children, adults, and elderly with various vaccines available at units or via home administration. Revenue from individual vaccine doses and vaccination packages.
4. Installment Payment (Dr. Cash Partnership): Partnership with Dr. Cash enables patients to pay for exams in up to 24 fixed installments, facilitating access to diagnostic services.
5. Health Insurance (Convênio): Services covered by health insurance plans (convênios), with billing through insurance providers.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Labs a+ is a diagnostic medicine brand operating clinical laboratory tests (blood, urine, toxicology, and other analyses), diagnostic imaging (wide-bore and open MRI, multislice CT, ultrasound, mammography, densitometry), and an extensive vaccination portfolio for children, adults, pregnant women, and seniors. Services are delivered through multiple physical units across Rio de Janeiro, supplemented by digital scheduling, mobile apps, and home collection services with waived visit fees for most offerings.

Product overview

Labs a+ is a diagnostic medicine company offering integrated laboratory testing, diagnostic imaging, and vaccination services across Rio de Janeiro, Brazil. The company operates as a unified brand formed from the merger of Labs D'Or and a+ Medicina Diagnóstica, combining laboratory tests (blood, urine, toxicology) with imaging diagnostics (MRI, CT, ultrasound, mammography, cardiac monitoring) in a network of physical units. The service portfolio includes core laboratory and imaging services, an extensive vaccination program for all ages (pediatric, adult, elderly, and prenatal), home collection services, digital scheduling via web/app, and secure online results access. The company accepts health insurance plans and offers Dr. Cash installment payment options.

Differentiator

Problem solved

Functional benefit

Products and services

• Laboratory Tests (Exames Laboratoriais) Comprehensive clinical analysis laboratory services including blood tests, urine tests, and other biological sample analyses performed across all Labs a+ units in Rio de Janeiro with standardized technical quality. Intended for patients referred by physicians or self-directed for preventive and routine health screening.
• Diagnostic Imaging (Exames de Imagem) Advanced imaging diagnostics including wide-bore magnetic resonance imaging, multislice computed tomography, ultrasonography, mammography, Doppler vascular studies, densitometry, and other diagnostic imaging procedures performed across multiple Rio de Janeiro units. Available to physician-referred patients and self-directed preventive screening patients.
• Vaccination Services (Vacinas) Extensive vaccine portfolio for children, adults, pregnant women, and seniors including pediatric vaccines (Pentavalent, Hexavalent, Rotavirus, MMR, Varicella), prenatal vaccines (dTpa, Abrysvo), travel vaccines (Yellow Fever, Typhoid), and adult/senior vaccines (HPV, Herpes Zoster, RSV, Pneumococcal, Influenza, Dengue Qdenga). Administered at units or via home visits.
• Home Healthcare Service (Atendimento Domiciliar) At-home specimen collection, blood tests, vaccinations, and cardiac monitoring (ambulatory blood pressure monitoring MAPA and Holter) provided across the Rio de Janeiro metropolitan area, including laboratory tests, vaccines, and urinary catheterization, with home visit fee waived for most services. Available to patients requiring convenience or with mobility limitations.
• Cardiac Diagnostics (Cardiologia) Cardiac examination services including electrocardiography, Holter monitoring, exercise stress testing (teste ergométrico), echocardiography, and ambulatory blood pressure monitoring (MAPA) for patients with cardiovascular concerns or physician referrals.
• Toxicology Testing (Exame Toxicológico) Toxicological examination services for occupational health compliance and driver licensing (CNH) requirements, available at the Bangu unit and other locations across Rio de Janeiro.
• Breast Health Diagnostics (Saúde da Mulher) Women's health diagnostic services including breast biopsy, bone densitometry, digital mammography, obstetric ultrasound, and fetal medicine assessments for female patients across reproductive, prenatal, and postmenopausal life stages.

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• Dr. CashcoreGTM or Marketing Partner · 4 March 2026Partnership enabling patients to pay for exams in up to 24 fixed installments. Available at all Labs a+ units, making diagnostic services more accessible and affordable. Eligibility and conditions apply.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Alliar Médicos à Frente: National Brazilian diagnostic medicine group operating laboratory and imaging services. Directly comparable as a multi-state competitor with similar integrated diagnostic portfolio.
• Dasa (Diagnósticos da América): Largest diagnostic medicine company in Brazil, operating laboratory, imaging, and hospital services across multiple states. Directly comparable to Labs a+ in core service offering (lab + imaging) and target consumer/B2B patient base.
• Grupo Pardini (Hermes Pardini): Established Brazilian diagnostic medicine group with laboratory, imaging, and specialized testing services. Comparable in service mix and target market of patients and health-plan providers.
• Sabin Diagnóstico e Saúde: Major Brazilian diagnostic medicine network with strong presence across multiple states. Directly comparable on integrated laboratory and imaging service model serving patients and health plans.

Emerging players

• Oncoclínicas: Specialty oncology diagnostics and treatment provider in Brazil. Compares on the high-end diagnostic testing and imaging capability, though more focused on oncology than general diagnostics.

Broad incumbents

• Hospital Israelita Albert Einstein: Major Brazilian hospital system that also operates a large outpatient diagnostic medicine business (lab + imaging). Comparable on integrated diagnostic service offering to premium patient segments.
• Sírio-Libanês: Premium Brazilian hospital and outpatient diagnostic provider in São Paulo. Comparable on integrated outpatient diagnostic lab and imaging services to private/insurance patients.
• Fleury S.A. Parent company of Labs a+ and one of the most established Brazilian diagnostic medicine brands. Operates a multi-brand portfolio across São Paulo and other states with overlapping lab, imaging, and vaccination services.
• Rede D'Or São Luiz: Largest private hospital network in Brazil with attached diagnostic services. Comparable on integrated care delivery model including lab and imaging diagnostics.

Regional players

• Diagnósticos do Brasil (DB Diagnósticos): Regional Brazilian diagnostic medicine provider with a footprint overlapping RJ and other states. Comparable on basic laboratory and imaging service model serving consumers and health plans.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/labsamais

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Labs a+